SCHEMBL561208

SCHEMBL561208

C=C(C(=O)O)C(F)C(F)(F)C(F)F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1448937 0.82
SCHEMBL1227973 0.80 TET2 (0.31)
SCHEMBL4930948 0.79
SCHEMBL10951965 0.77
SCHEMBL7148040 0.77
SCHEMBL2689625 0.76 TET2 (0.33)
SCHEMBL5412521 0.76 KDM4E (0.35)
SCHEMBL21581916 0.76 KDM4E (0.39)
SCHEMBL7155346 0.74
SCHEMBL4340459 0.74 TSHR (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 73 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119060267-A Regenerated PET composite material and preparation method thereof 上海中镭新材料科技有限公司 2024-12-03 CN claimed
EP-2563273-B1 INTRAVITREOUS SELF ADAPTIVE STENT EMPIRE TECHNOLOGY DEV LLC (US) 2017-08-23 EP claimed
US-9539087-B2 Intravitreous self adaptive stent EMPIRE TECHNOLOGY DEVELOPMENT LLC (US) 2017-01-10 US claimed
EP-2563273-A1 INTRAVITREOUS SELF ADAPTIVE STENT Empire Technology Development LLC (US) 2013-03-06 EP claimed
US-20120035738-A1 INTRAVITREOUS SELF ADAPTIVE STENT CRESTLINE DIRECT FINANCE, L.P. 2012-02-09 US claimed
WO-2011134146-A1 INTRAVITREOUS SELF ADAPTIVE STENT EMPIRE TECHNOLOGY DEVELOPMENT LLC (US) 2011-11-03 WO claimed
US-7374570-B2 Polymer compositions for intraluminal stent QUANAM MEDICAL CORPORATION (US) 2008-05-20 US claimed
US-20070073016-A1 Polymer compositions for intraluminal stent QUANAM MEDICAL CORPORATION 2007-03-29 US claimed
US-7115691-B2 Polymer compositions for intraluminal stent QUANAM MEDICAL CORPORATION (US) 2006-10-03 US claimed
US-20040059408-A1 Polymer compositions for intraluminal stent QUANAM MEDICAL CORPORATION 2004-03-25 US claimed
US-6653426-B2 Radially expandable; coaxial polymer comprising pentafluoropropyl acrylate and (heptadecyl fluorodecyl methacrylate) comonomers QUANAM MEDICAL CORPORATION 2003-11-25 US claimed
US-20030149470-A1 Polymer compositions for intraluminal stent QUANAM MEDICAL CORPORATION 2003-08-07 US claimed
US-6530950-B1 Radially expandable; rigid and flexible regions; polymer of such as pentafluoropropyl acrylate, polyethylene glycol methacrylate and methylmethacrylate QUANAM MEDICAL CORPORATION 2003-03-11 US claimed
EP-1140242-B1 POLYMER COMPOSITIONS FOR INTRALUMINAL STENT QUANAM MEDICAL CORP (US) 2002-10-30 EP claimed
EP-1140242-A1 POLYMER COMPOSITIONS FOR INTRALUMINAL STENT Quanam Medical Corporation (US) 2001-10-10 EP claimed
WO-2000041738-A1 POLYMER COMPOSITIONS FOR INTRALUMINAL STENT QUANAM MEDICAL CORPORATION (US) 2000-07-20 WO claimed
CN-119060267-A Regenerated PET composite material and preparation method thereof 上海中镭新材料科技有限公司 2024-12-03 CN disclosed
US-10894885-B2 Crosslinkable composition and method for producing a coated article HWK—KRONBICHLER GMBH (AT) 2021-01-19 US disclosed
EP-0109586-B1 PROCESS FOR MANUFACTURING LIGHT-GUIDING ARTICLES Montedison S.p.A. (IT) 1989-01-11 EP disclosed
US-4581252-A Process for providing optical products made of glassy polymers with a variable refractive index MONTEDISON S.P.A. (IT) 1986-04-08 US disclosed